Keyphrases
AIDS/HIV
73%
Peripheral Neuropathy
42%
HIV Neuropathy
39%
HIV Patients
34%
HIV Infection
33%
Botulinum Neurotoxin (BoNT)
32%
Cerebrospinal Fluid
30%
Human Immunodeficiency Virus Infection
29%
Antiretroviral Therapy
27%
Distal Symmetric Polyneuropathy
26%
Neuropathic Pain
25%
Progressive multifocal Leukoencephalopathy
24%
Neuropathy
24%
HIV-associated Neurocognitive Disorders
23%
Sensorimotor Polyneuropathy
23%
Highly Active Antiretroviral Therapy (HAART)
23%
HIV-associated
22%
Placebo
22%
Spasticity
21%
Myelopathy
18%
Myopathy
16%
Neurologic Complications
15%
AIDS Dementia Complex
15%
NGX-4010
15%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Antiretroviral
14%
Central Nervous System
12%
Zidovudine
12%
Neurocognitive Impairment
12%
Sensory Neuropathy
11%
Risk Factors
11%
Clinical Trials
10%
Combined Antiretroviral Therapy (cART)
10%
Nervous System
10%
HIV-related
10%
High Concentration
9%
Capsaicin 8% Patch
9%
Neuromuscular Complications
9%
HIV Viral Load
9%
Neuromuscular Disease
8%
Thalidomide
8%
Neurologic Disorders
8%
Capsaicin Patch
8%
CD4 Count
8%
Botulinum Toxin Injection
8%
Placebo-controlled Study
8%
HIV RNA
8%
Tolerability
7%
Placebo-controlled Trial
7%
American Academy of Neurology
7%
Medicine and Dentistry
Human Immunodeficiency Virus
96%
Polyneuropathy
43%
Human Immunodeficiency Virus Infection
37%
Peripheral Neuropathy
27%
Spasticity
24%
Neuropathy
24%
Neuropathic Pain
23%
Botulinum Toxin
21%
Placebo
19%
HIV-associated Neurocognitive Disorder
17%
Antiretroviral Therapy
17%
Spinal Cord Disease
16%
Disease
14%
Central Nervous System
13%
Progressive Multifocal Leukoencephalopathy
13%
Neurologic Disease
13%
Highly Active Antiretroviral Therapy
13%
Acquired Immune Deficiency Syndrome
12%
Sensory Neuropathy
11%
Neurological Complication
10%
Botulinum Toxin A
10%
Capsaicin
9%
Infection
9%
Clinical Trial
8%
Drug Therapy
8%
Weakness
7%
Adverse Event
6%
Upper Limb
6%
Nerve Fiber
6%
Cohort Effect
6%
Nervous System
6%
Diagnosis
6%
Cerebrospinal Fluid
5%
Numeric Rating Scale
5%
Apoplexy
5%
Placebo-Controlled Study
5%
Quality of Life
5%
Randomized Controlled Trial
5%
Tizanidine
5%
Pathophysiology
5%
Symptom
5%
Dermal Patch
5%
Recombinant Nerve Growth Factor
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Polyneuropathy
32%
Placebo
32%
Human Immunodeficiency Virus Infection
32%
Neuropathy
30%
Botulinum Toxin
24%
Neuropathic Pain
24%
Peripheral Neuropathy
20%
Spasticity
17%
HIV Associated Dementia
16%
Capsaicin
13%
Clinical Trial
12%
Neurological Complication
12%
Sensory Neuropathy
10%
Disease
10%
Spinal Cord Disease
9%
Neurologic Disease
8%
Thalidomide
8%
Adverse Event
8%
Zidovudine
8%
Tolerability
8%
Botulinum Toxin A
7%
Placebo-Controlled Study
7%
Lamictal
7%
Aphthous Stomatitis
7%
Symptom
6%
Antiretrovirus Agent
6%
Analgesic Agent
6%
Efavirenz
5%
Tizanidine
5%
Opiate
5%
Progressive Multifocal Leukoencephalopathy
5%
Virus Infection
5%
